Formoterol

BreastfeedingPediatric
  • TRADE NAMES: Dulera (Merck Sharpe & Dohme); Foradil (Novartis); Perforomist (Mylan); Symbicort (AstraZeneca)
  • INDICATIONS: Asthma, bronchospasm
  • CLASS: Beta-2 adrenergic agonist, Bronchodilator
  • HALF-LIFE: 10–14 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Beta blockers, Clomipramine, Desipramine, Doxepin, Imipramine, Iobenguane, Nortriptyline, Protriptyline, Trimipramine

PREGNANCY CATEGORY: C

NOTE

Dulera is formoterol and mometasone; Symbicort is formoterol and budesonide.

BLACK BOX WARNING
ASTHMA-RELATED DEATH

See full prescribing information for complete boxed warning.

Our database has 63 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
NEUROMUSCULAR/SKELETAL.
RESPIRATORY.
OTHER.


Page last updated 07/31/2023

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top